Building from our approach, we identified four new putative cancer genes (RWDD1, NCF1, PLEK, and VAV3), whose expression profiles were found to be associated with poor survival rates in melanoma, lung, or colon cancer patients. The gene discussed is NCF1; the disease is cancer.